These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 388712)

  • 21. [New discoveries on target blood pressure and ACE inhibitors. Swedish guidelines on hypertension are still correct].
    Ostergren J
    Lakartidningen; 1998 Aug; 95(32-33):3380-1. PubMed ID: 9725941
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of the hypotensive effect of captopril in patients with severe and treatment-resistant arterial hypertension].
    Grajek S; Paradowski S; Kozłowska F; Gracz M
    Kardiol Pol; 1988; 31(8):515-22. PubMed ID: 3072437
    [No Abstract]   [Full Text] [Related]  

  • 23. [Medication for borderline hypertension? Monitoring in low risk patients].
    Hense HW; Rosery H
    MMW Fortschr Med; 2002 Aug; 144(33-34):43-4. PubMed ID: 12380143
    [No Abstract]   [Full Text] [Related]  

  • 24. Concomitant considerations in long-term antihypertensive treatment.
    Holzgreve H; Middeke M
    J Hum Hypertens; 1990 Dec; 4 Suppl 5():11-8. PubMed ID: 2090833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the hypotensive effect of metoprolol (Betaloc-Astra)].
    Bielak J; Hanzlik J; Weglarz J; Narkiewicz-Jodko J
    Kardiol Pol; 1988; 31(2):99-106. PubMed ID: 3045399
    [No Abstract]   [Full Text] [Related]  

  • 26. [Epidemiology and diagnosis of hypertension in the Upper Silesian industrial region. II. Evaluation of the effectiveness of antihypertensive treatment in the industrialized and non-industrialized regions during the years 1977-1979].
    Kokot F; Kuska J; Baczyński R; Srokowska S; Wartenberg W; Jedrychowska M; Duda G; Bułanowski Z; Sledziński Z; Mleczko Z; Kuczera M; Wnuk R; Zielińska K; Dymarek I; Kuźmiak M
    Przegl Lek; 1982; 39(6):405-11. PubMed ID: 7134489
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
    Andersen K; Weinberger MH; Egan B; Constance CM; Ali MA; Jin J; Keefe DL
    J Hypertens; 2008 Mar; 26(3):589-99. PubMed ID: 18300872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [When and why to start drug therapy in essential hypertension].
    Oliva G; Fallani P; Mete A; Covello R; Avallone A
    Clin Ter; 1987 Oct; 123(1):51-5. PubMed ID: 2972467
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cardiac protection and antihypertensive therapy: facts and theories].
    Verdecchia P
    Minerva Med; 1986 Jun; 77(26):1259-70. PubMed ID: 3523304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the hypotensive effect of acebutolol (Sectral)].
    Brym E; Cybulska I; Czerniewska E
    Pol Tyg Lek; 1982 Nov; 37(44):1323-6. PubMed ID: 6761673
    [No Abstract]   [Full Text] [Related]  

  • 31. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of the optimal dose of the antihypertensive drug cicletanine hydrochloride in man.
    Guinot P; Jewitt-Harris J; Tarrade T
    Arzneimittelforschung; 1989 Jan; 39(1):86-9. PubMed ID: 2655611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
    Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
    Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The primary prevention of arterial hypertension. A meta-analysis of controlled clinical studies].
    Pop C; Garabagiu D; Bărbulescu B; Daraban D; Schisser G; Schiopu M; Zabreanu M; Roşu R; Fanea A; Popa A; Vlaicu R
    Rev Med Chir Soc Med Nat Iasi; 1999; 103(1-2):77-87. PubMed ID: 10756890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypotensive effect of physical activity and arterial hypertension].
    Kałka D; Sobieszczańska M; Marciniak W
    Pol Arch Med Wewn; 2006 Jun; 115(6):587-95. PubMed ID: 17263232
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypotensive effects of intravenous dichlorphenylaminoimidazoline.
    Kühns K; Oloffs J; Pohlmann F
    Ger Med Mon; 1968 Oct; 13(10):483-5. PubMed ID: 4884403
    [No Abstract]   [Full Text] [Related]  

  • 37. Antihypertensive drugs: praise and restraint.
    Proger S
    N Engl J Med; 1972 Jan; 286(3):155-6. PubMed ID: 4550140
    [No Abstract]   [Full Text] [Related]  

  • 38. The case for combination therapy in achieving blood pressure targets.
    Hosp Med; 1999 Jan; 60(1):50. PubMed ID: 10197099
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dynamics of physical work capacity in patients with hypertension after long-term hypotensive therapy].
    Tsikulin AE
    Kardiologiia; 1985 Jun; 25(6):43-6. PubMed ID: 4046310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of long-term anti-hypertensive treatment].
    Nishio I; Masuyama Y
    Nihon Rinsho; 1980 Sep; 38(9):3126-31. PubMed ID: 7253256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.